메뉴 건너뛰기




Volumn 39, Issue 9, 2013, Pages 1306-1316

Topical and intralesional treatment of nonmelanoma skin cancer: Efficacy and cost comparisons

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; BETA INTERFERON; BLEOMYCIN; FLUOROURACIL; GAMMA INTERFERON; IMIQUIMOD; METHOTREXATE; THYMIDYLATE SYNTHASE;

EID: 84883557025     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/dsu.12300     Document Type: Review
Times cited : (68)

References (71)
  • 1
    • 77956738766 scopus 로고    scopus 로고
    • Intralesional chemotherapy for nonmelanoma skin cancer: A practical review
    • Kirby JS, Miller CJ,. Intralesional chemotherapy for nonmelanoma skin cancer: a practical review. J Am Acad Dermatol 2010; 63: 689-702.
    • (2010) J Am Acad Dermatol , vol.63 , pp. 689-702
    • Kirby, J.S.1    Miller, C.J.2
  • 2
    • 79954562903 scopus 로고    scopus 로고
    • Lasers in the treatment of nonmelanoma skin cancer
    • Choudhary S, Tang J, Elsaie ML, Nouri K,. Lasers in the treatment of nonmelanoma skin cancer. Dermatol Surg 2011; 37: 409-25.
    • (2011) Dermatol Surg , vol.37 , pp. 409-425
    • Choudhary, S.1    Tang, J.2    Elsaie, M.L.3    Nouri, K.4
  • 3
    • 0141842584 scopus 로고    scopus 로고
    • Immunotherapy of basal cell carcinoma: Evolving approaches
    • Gaspari AA, Sauder DN,. Immunotherapy of basal cell carcinoma: evolving approaches. Dermatol Surg 2003; 29: 1027-34.
    • (2003) Dermatol Surg , vol.29 , pp. 1027-1034
    • Gaspari, A.A.1    Sauder, D.N.2
  • 5
    • 0035028717 scopus 로고    scopus 로고
    • Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: Results of a multicenter 6-week dose-response trial
    • Marks R, Gebauer K, Shumack S, Amies M, et al. Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: Results of a multicenter 6-week dose-response trial. J Am Acad Dermatol 2001; 44: 807-13.
    • (2001) J Am Acad Dermatol , vol.44 , pp. 807-813
    • Marks, R.1    Gebauer, K.2    Shumack, S.3    Amies, M.4
  • 6
    • 0036786195 scopus 로고    scopus 로고
    • An open case series of patients with basal cell carcinoma treated with topical 5% imiquimod cream
    • Cowen E, Mercurio MG, Gaspari AA,. An open case series of patients with basal cell carcinoma treated with topical 5% imiquimod cream. J Am Acad Dermatol 2002; 47: S240-8.
    • (2002) J Am Acad Dermatol , vol.47
    • Cowen, E.1    Mercurio, M.G.2    Gaspari, A.A.3
  • 7
    • 0036737628 scopus 로고    scopus 로고
    • Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: A double-blind, randomized, vehicle-controlled study
    • Geisse JK, Rich P, Pandya A, Gross K, et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study. J Am Acad Dermatol 2002; 47: 390-8.
    • (2002) J Am Acad Dermatol , vol.47 , pp. 390-398
    • Geisse, J.K.1    Rich, P.2    Pandya, A.3    Gross, K.4
  • 8
    • 0036886426 scopus 로고    scopus 로고
    • Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: Randomized studies comparing low-frequency dosing with and without occlusion
    • Sterry W, Ruzicka T, Herrera E, Takwale A, et al. Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion. Br J Dermatol 2002; 147: 1227-36.
    • (2002) Br J Dermatol , vol.147 , pp. 1227-1236
    • Sterry, W.1    Ruzicka, T.2    Herrera, E.3    Takwale, A.4
  • 9
    • 1842586450 scopus 로고    scopus 로고
    • Superficial and nodular basal cell carcinomas treated with an immune response modifier: A report of seven patients
    • Bianchi L, Costanzo A, Campione E, Nistico S, et al. Superficial and nodular basal cell carcinomas treated with an immune response modifier: a report of seven patients. Clin Exp Dermatol 2003; 28 (Suppl 1): 24-6.
    • (2003) Clin Exp Dermatol , vol.28 , Issue.SUPPL. 1 , pp. 24-26
    • Bianchi, L.1    Costanzo, A.2    Campione, E.3    Nistico, S.4
  • 10
    • 2342473348 scopus 로고    scopus 로고
    • Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: Results from two phase III, randomized, vehicle-controlled studies
    • Geisse J, Caro I, Lindholm J, Golitz L, et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol 2004; 50: 722-33.
    • (2004) J Am Acad Dermatol , vol.50 , pp. 722-733
    • Geisse, J.1    Caro, I.2    Lindholm, J.3    Golitz, L.4
  • 11
    • 5444228183 scopus 로고    scopus 로고
    • Efficacy and safety of 5% imiquimod cream in treating patients with multiple superficial basal cell carcinomas
    • Marks R, Owens M, Walters SA,. Efficacy and safety of 5% imiquimod cream in treating patients with multiple superficial basal cell carcinomas. Arch Dermatol 2004; 140: 1284-5.
    • (2004) Arch Dermatol , vol.140 , pp. 1284-1285
    • Marks, R.1    Owens, M.2    Walters, S.A.3
  • 12
    • 5444266559 scopus 로고    scopus 로고
    • 5% imiquimod cream for the treatment of large superficial basal cell carcinoma
    • Shumack S, Gebauer K, Quirk C, Macdonald K, et al. 5% imiquimod cream for the treatment of large superficial basal cell carcinoma. Arch Dermatol 2004; 140: 1286-7.
    • (2004) Arch Dermatol , vol.140 , pp. 1286-1287
    • Shumack, S.1    Gebauer, K.2    Quirk, C.3    Macdonald, K.4
  • 13
    • 18244384077 scopus 로고    scopus 로고
    • Imiquimod treatment of superficial and nodular basal cell carcinoma: 12-week open-label trial
    • Peris K, Campione E, Micantonio T, Marulli GC, et al. Imiquimod treatment of superficial and nodular basal cell carcinoma: 12-week open-label trial. Dermatol Surg 2005; 31: 318-23.
    • (2005) Dermatol Surg , vol.31 , pp. 318-323
    • Peris, K.1    Campione, E.2    Micantonio, T.3    Marulli, G.C.4
  • 14
    • 18944395052 scopus 로고    scopus 로고
    • Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: Results from a randomized vehicle-controlled phase III study in Europe
    • Schulze HJ, Cribier B, Requena L, Reifenberger J, et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe. Br J Dermatol 2005; 152: 939-47.
    • (2005) Br J Dermatol , vol.152 , pp. 939-947
    • Schulze, H.J.1    Cribier, B.2    Requena, L.3    Reifenberger, J.4
  • 15
    • 33745744243 scopus 로고    scopus 로고
    • Use of 5% imiquimod cream in the treatment of facial basal cell carcinoma: A 3-year retrospective follow-up study
    • Vun Y, Siller G,. Use of 5% imiquimod cream in the treatment of facial basal cell carcinoma: a 3-year retrospective follow-up study. Australas J Dermatol 2006; 47: 169-71.
    • (2006) Australas J Dermatol , vol.47 , pp. 169-171
    • Vun, Y.1    Siller, G.2
  • 16
    • 34548787163 scopus 로고    scopus 로고
    • Treatment of all basal cell carcinoma variants including large and high-risk lesions with 5% imiquimod cream: Histological and clinical changes, outcome, and follow-up
    • Schiessl C, Wolber C, Tauber M, Offner F, et al. Treatment of all basal cell carcinoma variants including large and high-risk lesions with 5% imiquimod cream: histological and clinical changes, outcome, and follow-up. J Drugs Dermatol 2007; 6: 507-13.
    • (2007) J Drugs Dermatol , vol.6 , pp. 507-513
    • Schiessl, C.1    Wolber, C.2    Tauber, M.3    Offner, F.4
  • 17
    • 33847145490 scopus 로고    scopus 로고
    • Fifty-five basal cell carcinomas treated with topical imiquimod: Outcome at 5-year follow-up
    • Vidal D, Matias-Guiu X, Alomar A,. Fifty-five basal cell carcinomas treated with topical imiquimod: outcome at 5-year follow-up. Arch Dermatol 2007; 143: 266-8.
    • (2007) Arch Dermatol , vol.143 , pp. 266-268
    • Vidal, D.1    Matias-Guiu, X.2    Alomar, A.3
  • 18
    • 57749201993 scopus 로고    scopus 로고
    • Recurrence rate of superficial basal cell carcinoma following treatment with imiquimod 5% cream: Conclusion of a 5-year long-term follow-up study in Europe
    • Gollnick H, Barona CG, Frank RG, Ruzicka T, et al. Recurrence rate of superficial basal cell carcinoma following treatment with imiquimod 5% cream: conclusion of a 5-year long-term follow-up study in Europe. Eur J Dermatol 2008; 18: 677-82.
    • (2008) Eur J Dermatol , vol.18 , pp. 677-682
    • Gollnick, H.1    Barona, C.G.2    Frank, R.G.3    Ruzicka, T.4
  • 19
    • 77955778580 scopus 로고    scopus 로고
    • Sustained clearance of superficial basal cell carcinomas treated with imiquimod cream 5%: Results of a prospective 5-year study
    • Quirk C, Gebauer K, De'Ambrosis B, Slade HB, et al. Sustained clearance of superficial basal cell carcinomas treated with imiquimod cream 5%: results of a prospective 5-year study. Cutis 2010; 85: 318-24.
    • (2010) Cutis , vol.85 , pp. 318-324
    • Quirk, C.1    Gebauer, K.2    De'Ambrosis, B.3    Slade, H.B.4
  • 20
    • 84883555820 scopus 로고    scopus 로고
    • Valeant Pharmaceuticals International. Costa Mesa (CA): Valeant Pharmaceuticals International
    • Valeant Pharmaceuticals International. Efudex-40™ (fluorouracil topical cream) prescribing information. Costa Mesa (CA): Valeant Pharmaceuticals International; 2004.
    • (2004) Efudex-40™ (Fluorouracil Topical Cream) Prescribing Information
  • 21
    • 34147123685 scopus 로고    scopus 로고
    • 5% 5-fluorouracil cream for the treatment of small superficial Basal cell carcinoma: Efficacy, tolerability, cosmetic outcome, and patient satisfaction
    • discussion 40
    • Gross K, Kircik L,. 5% 5-fluorouracil cream for the treatment of small superficial Basal cell carcinoma: efficacy, tolerability, cosmetic outcome, and patient satisfaction. Dermatol Surg 2007; 33: 433-9; discussion 40.
    • (2007) Dermatol Surg , vol.33 , pp. 433-439
    • Gross, K.1    Kircik, L.2
  • 22
    • 0036715342 scopus 로고    scopus 로고
    • Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: Comparison of dosing regimens
    • Shumack S, Robinson J, Kossard S, Golitz L, et al. Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens. Arch Dermatol 2002; 138: 1165-71.
    • (2002) Arch Dermatol , vol.138 , pp. 1165-1171
    • Shumack, S.1    Robinson, J.2    Kossard, S.3    Golitz, L.4
  • 23
    • 1942504386 scopus 로고    scopus 로고
    • Topical imiquimod treatment for nodular basal cell carcinomas: An open-label series
    • Huber A, Huber JD, Skinner RB Jr, Kuwahara RT, et al. Topical imiquimod treatment for nodular basal cell carcinomas: an open-label series. Dermatol Surg 2004; 30: 429-30.
    • (2004) Dermatol Surg , vol.30 , pp. 429-430
    • Huber, A.1    Huber, J.D.2    Skinner, Jr.R.B.3    Kuwahara, R.T.4
  • 24
    • 34548531036 scopus 로고    scopus 로고
    • A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma
    • Eigentler TK, Kamin A, Weide BM, Breuninger H, et al. A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma. J Am Acad Dermatol 2007; 57: 616-21.
    • (2007) J Am Acad Dermatol , vol.57 , pp. 616-621
    • Eigentler, T.K.1    Kamin, A.2    Weide, B.M.3    Breuninger, H.4
  • 27
    • 1642416709 scopus 로고    scopus 로고
    • Treatment of Bowen's disease with imiquimod 5% cream in transplant recipients
    • Prinz BM, Hafner J, Dummer R, Burg G, et al. Treatment of Bowen's disease with imiquimod 5% cream in transplant recipients. Transplantation 2004; 77: 790-1.
    • (2004) Transplantation , vol.77 , pp. 790-791
    • Prinz, B.M.1    Hafner, J.2    Dummer, R.3    Burg, G.4
  • 29
    • 33646531439 scopus 로고    scopus 로고
    • Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen's disease): A randomized, double-blind, placebo-controlled trial
    • Patel GK, Goodwin R, Chawla M, Laidler P, et al. Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen's disease): a randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol 2006; 54: 1025-32.
    • (2006) J Am Acad Dermatol , vol.54 , pp. 1025-1032
    • Patel, G.K.1    Goodwin, R.2    Chawla, M.3    Laidler, P.4
  • 30
    • 33745843689 scopus 로고    scopus 로고
    • Imiquimod 5% cream in the treatment of Bowen's disease and invasive squamous cell carcinoma
    • Peris K, Micantonio T, Fargnoli MC, Lozzi GP, et al. Imiquimod 5% cream in the treatment of Bowen's disease and invasive squamous cell carcinoma. J Am Acad Dermatol 2006; 55: 324-7.
    • (2006) J Am Acad Dermatol , vol.55 , pp. 324-327
    • Peris, K.1    Micantonio, T.2    Fargnoli, M.C.3    Lozzi, G.P.4
  • 31
    • 34147137132 scopus 로고    scopus 로고
    • Treatment of Bowen's disease with topical 5% imiquimod cream: Retrospective study
    • discussion 31-2
    • Rosen T, Harting M, Gibson M,. Treatment of Bowen's disease with topical 5% imiquimod cream: retrospective study. Dermatol Surg 2007; 33: 427-31; discussion 31-2.
    • (2007) Dermatol Surg , vol.33 , pp. 427-431
    • Rosen, T.1    Harting, M.2    Gibson, M.3
  • 32
    • 80052084693 scopus 로고    scopus 로고
    • Treatment of keratoacanthoma with 5% imiquimod cream and review of the previous report
    • Jeon HC, Choi M, Paik SH, Ahn CH, et al. Treatment of keratoacanthoma with 5% imiquimod cream and review of the previous report. Ann Dermatol 2011; 23: 357-61.
    • (2011) Ann Dermatol , vol.23 , pp. 357-361
    • Jeon, H.C.1    Choi, M.2    Paik, S.H.3    Ahn, C.H.4
  • 33
    • 0037366476 scopus 로고    scopus 로고
    • Topical treatment of Bowen's disease with 5-Fluorouracil
    • Bargman H, Hochman J,. Topical treatment of Bowen's disease with 5-Fluorouracil. J Cutan Med Surg 2003; 7: 101-5.
    • (2003) J Cutan Med Surg , vol.7 , pp. 101-105
    • Bargman, H.1    Hochman, J.2
  • 34
    • 0037362509 scopus 로고    scopus 로고
    • Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease
    • Salim A, Leman JA, McColl JH, Chapman R, et al. Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease. Br J Dermatol 2003; 148: 539-43.
    • (2003) Br J Dermatol , vol.148 , pp. 539-543
    • Salim, A.1    Leman, J.A.2    McColl, J.H.3    Chapman, R.4
  • 35
    • 33745229420 scopus 로고    scopus 로고
    • Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial
    • Morton C, Horn M, Leman J, Tack B, et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: results of a multicenter randomized trial. Arch Dermatol 2006; 142: 729-35.
    • (2006) Arch Dermatol , vol.142 , pp. 729-735
    • Morton, C.1    Horn, M.2    Leman, J.3    Tack, B.4
  • 36
    • 0017157488 scopus 로고
    • Intradermal 5-fluorouracil in the treatment of basal cell carcinoma of the face
    • Avant WH, Huff RC,. Intradermal 5-fluorouracil in the treatment of basal cell carcinoma of the face. South Med J 1976; 69: 561-3.
    • (1976) South Med J , vol.69 , pp. 561-563
    • Avant, W.H.1    Huff, R.C.2
  • 37
    • 0018840425 scopus 로고
    • Treatment of cutaneous neoplasms by intralesional injections of 5-fluorouracil (5-FU)
    • Kurtis B, Rosen T,. Treatment of cutaneous neoplasms by intralesional injections of 5-fluorouracil (5-FU). J Dermatol Surg Oncol 1980; 6: 122-7.
    • (1980) J Dermatol Surg Oncol , vol.6 , pp. 122-127
    • Kurtis, B.1    Rosen, T.2
  • 38
    • 0002726755 scopus 로고
    • Tumors of the skin. II. Keratoacanthoma; Local effct of 5-fluorouracil
    • Klein E, Helm F, Milgrom H, Stoll HL Jr, et al. Tumors of the skin. II. Keratoacanthoma; local effct of 5-fluorouracil. Skin (Los Angeles) 1962; 1: 153-6.
    • (1962) Skin (Los Angeles) , vol.1 , pp. 153-156
    • Klein, E.1    Helm, F.2    Milgrom, H.3    Stoll, Jr.H.L.4
  • 39
    • 0018988739 scopus 로고
    • Successful treatment of keratoacanthoma with intralesional fluorouracil
    • Goette DK, Odom RB,. Successful treatment of keratoacanthoma with intralesional fluorouracil. J Am Acad Dermatol 1980; 2: 212-6.
    • (1980) J Am Acad Dermatol , vol.2 , pp. 212-216
    • Goette, D.K.1    Odom, R.B.2
  • 40
    • 0022651257 scopus 로고
    • Large keratoacanthomas in difficult locations treated with intralesional 5-fluorouracil
    • Parker CM, Hanke CW,. Large keratoacanthomas in difficult locations treated with intralesional 5-fluorouracil. J Am Acad Dermatol 1986; 14: 770-7.
    • (1986) J Am Acad Dermatol , vol.14 , pp. 770-777
    • Parker, C.M.1    Hanke, C.W.2
  • 42
    • 0031957639 scopus 로고    scopus 로고
    • Intralesional methotrexate in solitary keratoacanthoma
    • Cuesta-Romero C, de Grado-Pena J,. Intralesional methotrexate in solitary keratoacanthoma. Arch Dermatol 1998; 134: 513-4.
    • (1998) Arch Dermatol , vol.134 , pp. 513-514
    • Cuesta-Romero, C.1    De Grado-Pena, J.2
  • 43
    • 34248140144 scopus 로고    scopus 로고
    • Intralesional methotrexate treatment for keratoacanthoma tumors: A retrospective study and review of the literature
    • Annest NM, VanBeek MJ, Arpey CJ, Whitaker DC,. Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective study and review of the literature. J Am Acad Dermatol 2007; 56: 989-93.
    • (2007) J Am Acad Dermatol , vol.56 , pp. 989-993
    • Annest, N.M.1    Vanbeek, M.J.2    Arpey, C.J.3    Whitaker, D.C.4
  • 44
    • 0015277479 scopus 로고
    • Effect of bleomycin on benign and malignant cutaneous tumours
    • Mishima Y, Matunaka M,. Effect of bleomycin on benign and malignant cutaneous tumours. Acta Derm Venereol 1972; 52: 211-5.
    • (1972) Acta Derm Venereol , vol.52 , pp. 211-215
    • Mishima, Y.1    Matunaka, M.2
  • 45
    • 0020525263 scopus 로고
    • Treatment of keratoacanthoma with intralesional bleomycin
    • Sayama S, Tagami H,. Treatment of keratoacanthoma with intralesional bleomycin. Br J Dermatol 1983; 109: 449-52.
    • (1983) Br J Dermatol , vol.109 , pp. 449-452
    • Sayama, S.1    Tagami, H.2
  • 47
    • 0024501706 scopus 로고
    • Treatment of neoplastic skin lesions with intralesional interferon
    • Wickramasinghe L, Hindson TC, Wacks H,. Treatment of neoplastic skin lesions with intralesional interferon. J Am Acad Dermatol 1989; 20: 71-4.
    • (1989) J Am Acad Dermatol , vol.20 , pp. 71-74
    • Wickramasinghe, L.1    Hindson, T.C.2    Wacks, H.3
  • 48
    • 0023928771 scopus 로고
    • Treatment of large basal-cell carcinomas with intralesional interferon-alpha-2a
    • Grob JJ, Collet AM, Munoz MH, Bonerandi JJ,. Treatment of large basal-cell carcinomas with intralesional interferon-alpha-2a. Lancet 1988; 1: 878-9.
    • (1988) Lancet , vol.1 , pp. 878-879
    • Grob, J.J.1    Collet, A.M.2    Munoz, M.H.3    Bonerandi, J.J.4
  • 49
    • 0029068096 scopus 로고
    • Intralesional alfa-2a interferon therapy for basal cell carcinoma
    • Dogan B, Harmanyeri Y, Baloglu H, Oztek I,. Intralesional alfa-2a interferon therapy for basal cell carcinoma. Cancer Lett 1995; 91: 215-9.
    • (1995) Cancer Lett , vol.91 , pp. 215-219
    • Dogan, B.1    Harmanyeri, Y.2    Baloglu, H.3    Oztek, I.4
  • 50
    • 0029057234 scopus 로고
    • Treatment of basal cell carcinoma with intralesional interferon alpha-2a
    • LeGrice P, Baird E, Hodge L,. Treatment of basal cell carcinoma with intralesional interferon alpha-2a. N Z Med J 1995; 108: 206-7.
    • (1995) N Z Med J , vol.108 , pp. 206-207
    • Legrice, P.1    Baird, E.2    Hodge, L.3
  • 51
    • 0030056075 scopus 로고    scopus 로고
    • Comparison of the effects of intralesional interferon alfa-2a, 2b and the combination of 2a and 2b in the treatment of basal cell carcinoma
    • Alpsoy E, Yilmaz E, Basaran E, Yazar S,. Comparison of the effects of intralesional interferon alfa-2a, 2b and the combination of 2a and 2b in the treatment of basal cell carcinoma. J Dermatol 1996; 23: 394-6.
    • (1996) J Dermatol , vol.23 , pp. 394-396
    • Alpsoy, E.1    Yilmaz, E.2    Basaran, E.3    Yazar, S.4
  • 52
    • 24944590701 scopus 로고    scopus 로고
    • Treatment of Basal Cell Carcinoma Located in the Head and Neck Region with Intralesional Interferon alpha-2a: Evaluation of Long-Term Follow-Up Results
    • Bostanci S, Kocyigit P, Alp A, Erdem C, et al. Treatment of Basal Cell Carcinoma Located in the Head and Neck Region with Intralesional Interferon alpha-2a: evaluation of Long-Term Follow-Up Results. Clin Drug Investig 2005; 25: 661-7.
    • (2005) Clin Drug Investig , vol.25 , pp. 661-667
    • Bostanci, S.1    Kocyigit, P.2    Alp, A.3    Erdem, C.4
  • 53
    • 0027221095 scopus 로고
    • Large keratoacanthomas treated with intralesional interferon alfa-2a
    • Grob JJ, Suzini F, Richard MA, Weiller M, et al. Large keratoacanthomas treated with intralesional interferon alfa-2a. J Am Acad Dermatol 1993; 29: 237-41.
    • (1993) J Am Acad Dermatol , vol.29 , pp. 237-241
    • Grob, J.J.1    Suzini, F.2    Richard, M.A.3    Weiller, M.4
  • 55
    • 0025298152 scopus 로고
    • The effect of an intralesional sustained-release formulation of interferon alfa-2b on basal cell carcinomas
    • Edwards L, Tucker SB, Perednia D, Smiles KA, et al. The effect of an intralesional sustained-release formulation of interferon alfa-2b on basal cell carcinomas. Arch Dermatol 1990; 126: 1029-32.
    • (1990) Arch Dermatol , vol.126 , pp. 1029-1032
    • Edwards, L.1    Tucker, S.B.2    Perednia, D.3    Smiles, K.A.4
  • 56
    • 0025351873 scopus 로고
    • Immunohistological evaluation of basal cell carcinoma immunoinfiltrate during intralesional treatment with alpha 2-interferon
    • Mozzanica N, Cattaneo A, Boneschi V, Brambilla L, et al. Immunohistological evaluation of basal cell carcinoma immunoinfiltrate during intralesional treatment with alpha 2-interferon. Arch Dermatol Res 1990; 282: 311-7.
    • (1990) Arch Dermatol Res , vol.282 , pp. 311-317
    • Mozzanica, N.1    Cattaneo, A.2    Boneschi, V.3    Brambilla, L.4
  • 57
    • 0024998053 scopus 로고
    • Intralesional interferon-alpha 2b treatment of basal cell carcinoma
    • Thestrup-Pedersen K, Jacobsen IE, Frentz G,. Intralesional interferon-alpha 2b treatment of basal cell carcinoma. Acta Derm Venereol 1990; 70: 512-4.
    • (1990) Acta Derm Venereol , vol.70 , pp. 512-514
    • Thestrup-Pedersen, K.1    Jacobsen, I.E.2    Frentz, G.3
  • 58
    • 0026027170 scopus 로고
    • Intralesional alpha 2b recombinant interferon for basal cell carcinomas
    • Boneschi V, Brambilla L, Chiappino G, Mozzanica N, et al. Intralesional alpha 2b recombinant interferon for basal cell carcinomas. Int J Dermatol 1991; 30: 220-4.
    • (1991) Int J Dermatol , vol.30 , pp. 220-224
    • Boneschi, V.1    Brambilla, L.2    Chiappino, G.3    Mozzanica, N.4
  • 60
    • 0028228904 scopus 로고
    • Treatment of basal cell carcinoma with intralesional interferon alpha-2b: Evaluation of efficacy with emphasis on tumors located on 'H' zone of the face
    • Pizarro A, Fonseca E,. Treatment of basal cell carcinoma with intralesional interferon alpha-2b: evaluation of efficacy with emphasis on tumors located on 'H' zone of the face. Eur J Dermatol 1994; 4: 287-90.
    • (1994) Eur J Dermatol , vol.4 , pp. 287-290
    • Pizarro, A.1    Fonseca, E.2
  • 61
    • 0028916478 scopus 로고
    • Use of recombinant interferon alfa-2b in the treatment of basal cell carcinoma
    • Chimenti S, Peris K, Di Cristofaro S, Fargnoli MC, et al. Use of recombinant interferon alfa-2b in the treatment of basal cell carcinoma. Dermatology 1995; 190: 214-7.
    • (1995) Dermatology , vol.190 , pp. 214-217
    • Chimenti, S.1    Peris, K.2    Di Cristofaro, S.3    Fargnoli, M.C.4
  • 62
    • 33646509240 scopus 로고    scopus 로고
    • Long-term follow-up of basal cell carcinomas treated with perilesional interferon alfa 2b as monotherapy
    • Tucker SB, Polasek JW, Perri AJ, Goldsmith EA,. Long-term follow-up of basal cell carcinomas treated with perilesional interferon alfa 2b as monotherapy. J Am Acad Dermatol 2006; 54: 1033-8.
    • (2006) J Am Acad Dermatol , vol.54 , pp. 1033-1038
    • Tucker, S.B.1    Polasek, J.W.2    Perri, A.J.3    Goldsmith, E.A.4
  • 63
    • 0026693223 scopus 로고
    • Treatment of aggressive basal cell carcinoma with intralesional interferon: Evaluation of efficacy by Mohs surgery
    • Stenquist B, Wennberg AM, Gisslen H, Larko O,. Treatment of aggressive basal cell carcinoma with intralesional interferon: evaluation of efficacy by Mohs surgery. J Am Acad Dermatol 1992; 27: 65-9.
    • (1992) J Am Acad Dermatol , vol.27 , pp. 65-69
    • Stenquist, B.1    Wennberg, A.M.2    Gisslen, H.3    Larko, O.4
  • 64
    • 0842333115 scopus 로고    scopus 로고
    • Intralesional interferon alpha-2b in the treatment of basal cell carcinoma and squamous cell carcinoma: Revisited
    • Kim KH, Yavel RM, Gross VL, Brody N,. Intralesional interferon alpha-2b in the treatment of basal cell carcinoma and squamous cell carcinoma: revisited. Dermatol Surg 2004; 30: 116-20.
    • (2004) Dermatol Surg , vol.30 , pp. 116-120
    • Kim, K.H.1    Yavel, R.M.2    Gross, V.L.3    Brody, N.4
  • 65
    • 16644397926 scopus 로고    scopus 로고
    • Intralesional interferon alfa-2b treatment of keratoacanthomas
    • Oh CK, Son HS, Lee JB, Jang HS, et al. Intralesional interferon alfa-2b treatment of keratoacanthomas. J Am Acad Dermatol 2004; 51: S177-80.
    • (2004) J Am Acad Dermatol , vol.51
    • Oh, C.K.1    Son, H.S.2    Lee, J.B.3    Jang, H.S.4
  • 66
    • 0026490144 scopus 로고
    • Treatment of cutaneous squamous cell carcinomas by intralesional interferon alfa-2b therapy
    • Edwards L, Berman B, Rapini RP, Whiting DA, et al. Treatment of cutaneous squamous cell carcinomas by intralesional interferon alfa-2b therapy. Arch Dermatol 1992; 128: 1486-9.
    • (1992) Arch Dermatol , vol.128 , pp. 1486-1489
    • Edwards, L.1    Berman, B.2    Rapini, R.P.3    Whiting, D.A.4
  • 67
    • 0028101334 scopus 로고
    • Treatment of basal cell carcinoma with intralesional recombinant interferon beta: A dose-finding study
    • Kowalzick L, Rogozinski T, Schober C, Fierlbeck G, et al. Treatment of basal cell carcinoma with intralesional recombinant interferon beta: a dose-finding study. Eur J Dermatol 1994; 4: 430-3.
    • (1994) Eur J Dermatol , vol.4 , pp. 430-433
    • Kowalzick, L.1    Rogozinski, T.2    Schober, C.3    Fierlbeck, G.4
  • 68
    • 0036861010 scopus 로고    scopus 로고
    • Intralesional recombinant interferon beta-1a in the treatment of basal cell carcinoma: Results of an open-label multicentre study
    • Kowalzick L, Rogozinski T, Wimheuer R, Pilz J, et al. Intralesional recombinant interferon beta-1a in the treatment of basal cell carcinoma: results of an open-label multicentre study. Eur J Dermatol 2002; 12: 558-61.
    • (2002) Eur J Dermatol , vol.12 , pp. 558-561
    • Kowalzick, L.1    Rogozinski, T.2    Wimheuer, R.3    Pilz, J.4
  • 69
    • 0025314154 scopus 로고
    • The effect of intralesional interferon gamma on basal cell carcinomas
    • Edwards L, Whiting D, Rogers D, Luck K, et al. The effect of intralesional interferon gamma on basal cell carcinomas. J Am Acad Dermatol 1990; 22: 496-500.
    • (1990) J Am Acad Dermatol , vol.22 , pp. 496-500
    • Edwards, L.1    Whiting, D.2    Rogers, D.3    Luck, K.4
  • 70
    • 0024444729 scopus 로고
    • Intralesional treatment of basal cell carcinoma with low-dose recombinant interferon gamma
    • Tank B, Habets JM, Naafs B, Damsma O, et al. Intralesional treatment of basal cell carcinoma with low-dose recombinant interferon gamma. J Am Acad Dermatol 1989; 21: 734-5.
    • (1989) J Am Acad Dermatol , vol.21 , pp. 734-735
    • Tank, B.1    Habets, J.M.2    Naafs, B.3    Damsma, O.4
  • 71
    • 0032723959 scopus 로고    scopus 로고
    • Differentiating squamous cell carcinoma from keratoacanthoma using histopathological criteria. Is it possible? A study of 296 cases
    • Cribier B, Asch P, Grosshans E,. Differentiating squamous cell carcinoma from keratoacanthoma using histopathological criteria. Is it possible? A study of 296 cases. Dermatology 1999; 199: 208-12
    • (1999) Dermatology , vol.199 , pp. 208-212
    • Cribier, B.1    Asch, P.2    Grosshans, E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.